|
NLN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.362800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.695600E-01 |
| Normal-vs-Stage2 |
5.086200E-01 |
| Normal-vs-Stage3 |
2.661400E-01 |
| Normal-vs-Stage4 |
7.605200E-01 |
| Stage1-vs-Stage2 |
6.481600E-01 |
| Stage1-vs-Stage3 |
2.994800E-01 |
| Stage1-vs-Stage4 |
9.088200E-01 |
| Stage2-vs-Stage3 |
7.277000E-01 |
| Stage2-vs-Stage4 |
8.424800E-01 |
| Stage3-vs-Stage4 |
6.470400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.143600E-01 |
| Normal-vs-AfricanAmerican |
5.834200E-01 |
| Normal-vs-Asian |
4.689400E-01 |
| Caucasian-vs-AfricanAmerican |
8.274400E-01 |
| Caucasian-vs-Asian |
5.466800E-01 |
| AfricanAmerican-vs-Asian |
5.250400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.267600E-01 |
| Normal-vs-Female |
1.382670E-03 |
| Male-vs-Female |
3.826000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.975400E-01 |
| Normal-vs-Extreme_Weight |
2.108800E-01 |
| Normal-vs-Obese |
4.601400E-01 |
| Normal-vs-Extreme_Obese |
5.434200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.315000E-01 |
| Normal_Weight-vs-Obese |
8.366200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.508400E-01 |
| Extreme_Weight-vs-Obese |
9.149700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.311200E-01 |
| Obese-vs-Extreme_Obese |
7.101000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.002400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.463600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.192200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.569600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.501800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.298000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.046600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.709600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.395800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.543400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.044800E-01 |
| Normal-VS-Type2 PRCC |
9.502800E-03 |
| Normal-VS-KIRP CIMP |
5.139900E-02 |
| Normal-VS-Unclassified PRCC |
9.691600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.223770E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.000600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.707600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.274400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.835800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.164200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.213800E-01 |
| Normal-vs-N1 |
8.944000E-02 |
| Normal-vs-N2 |
7.558000E-01 |
| N0-vs-N1 |
8.247600E-02 |
| N0-vs-N2 |
7.144200E-01 |
| N1-vs-N2 |
6.691200E-01 |
|
|
